Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01999894 · ClinicalTrials.gov registry record · Phase 2

Open-label Study of Safety and Tolerability of Memantine in Children With Autism

A Phase 2 study of Autism and Pediatric Autism, sponsored by Forest Laboratories.

Completed
Registry status
Phase 2
Development phase
102
Enrollment target
19
Study locations

NCT01999894 is a Phase 2 study of Autism and Pediatric Autism that has completed, run by Forest Laboratories. The registered enrollment target is 102 participants, below the 182-participant average among 104 other Autism trials with a reported enrollment target (44% lower). The trial reports 19 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01999894, a Phase 2 study of Autism and Pediatric Autism, has completed, sponsored by Forest Laboratories.

COMPLETED
Registry status
Phase 2
Development phase
102 participants
Enrollment target
19
Study locations

Study Summary

The purpose of this study is to evaluate the long-term safety and tolerability of memantine in the treatment of autism in pediatric patients.

Conditions Studied

Autism Pediatric Autism

Interventions

  • DRUG Memantine HCl

Study Locations (19)

California

  • Forest Investigative Site 003 - Sacramento
  • Forest Investigative Site 021 - San Francisco
  • Forest Investigative Site 026 - Santa Ana
  • Forest Investigative Site 020 - Santa Ana
  • Forest Investigative Site 002 - Stanford

Ohio

  • Forest Investigative Site 013 - Cleveland
  • Forest Investigative Site 015 - Cleveland
  • Forest Investigative Site 001 - Columbus

Florida

  • Forest Investigative Site 024 - Jacksonville Beach
  • Forest Investigative Site 007 - St. Petersburg

Illinois

  • Forest Investigative Site 014 - Hoffman Estates
  • Forest Investigative Site 023 - Naperville

New Jersey

  • Forest Investigative Site 011 - Toms River
  • Forest Investigative Site 006 - Voorhees Township

Arizona

  • Forest Investigative Site 005 - Phoenix

Indiana

  • Forest Investigative Site 010 - Indianapolis

Massachusetts

  • Forest Investigative Site 025 - Cambridge

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2009-11
Est. Completion 2013-02
Phase Phase 2

Sponsor

Forest Laboratories

145 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01999894

The ClinicalTrials.gov registry entry for NCT01999894 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 182-participant average among 104 other Autism trials with a reported enrollment target (44% lower). The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Memantine HCl is the first listed.

NCT01999894 reports 19 study locations spanning 10 distinct geographic areas - top geographies include California, Ohio, Florida.

Frequently Asked Questions

What is clinical trial NCT01999894 about?

NCT01999894 is a clinical study titled "Open-label Study of Safety and Tolerability of Memantine in Children With Autism". The purpose of this study is to evaluate the long-term safety and tolerability of memantine in the treatment of autism in pediatric patients.

What is the current status of trial NCT01999894?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 102 participants. The study started on 2009-11. Estimated completion is 2013-02.

What conditions does trial NCT01999894 study?

This clinical trial studies the following conditions: Autism, Pediatric Autism.

What interventions are being tested in trial NCT01999894?

The interventions under investigation include: Memantine HCl (DRUG).

Who is sponsoring clinical trial NCT01999894?

This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01999894 being conducted?

This trial has 19 study locations across Arizona, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism

All registered trials for this condition

Pediatric Autism

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.